Wide Ranks

AXDX

Accelerate Diagnostics, Inc.

1.61

Top Statistics
Market Cap 40 M Forward PE -0.9415 Revenue Growth 2.20 %
Current Ratio 1.28 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.95 Enterprise / Revenue 6.48 Price To Sales Trailing12 Months 3.30
Profitability
Profit Margins 0.00 % Operating Margins -288.21 %
Balance Sheet
Total Cash 9 M Total Cash Per Share 0.4120 Total Debt 42 M
Total Debt To Equity Current Ratio 1.28 Book Value Per Share -1.36
All Measures
Short Ratio 777.00 % Message Board Id finmb_363801 Shares Short Prior Month 468347
City Tucson Uuid a602e4de-ddad-3ecf-864d-d40f7da91eac Previous Close 1.65
First Trade Date Epoch Utc 765 M Book Value -1.36 Beta 0.5980
Total Debt 42 M Volume 44521 Last Split Date 1 B
Fifty Two Week Low 0.7300 Total Cash Per Share 0.4120 Total Revenue 12 M
Shares Short Previous Month Date 1 B Audit Risk 10 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins -288.21 % Net Income To Common -37906000
Short Percent Of Float 0.0305 Implied Shares Outstanding 25 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 44820 Average Volume10days 44820
Total Cash 9 M Next Fiscal Year End 1 B Revenue Per Share 0.6650
Held Percent Insiders 0.4061 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 2 Regular Market Previous Close 1.65
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.80
Open 1.58 Free Cashflow -54674248 State AZ
Dividend Yield 0.00 % Return On Assets -0.7585 Time Zone Short Name EST
Board Risk 3 Trailing Eps -2.59 Day Low 1.58
Address1 3950 South Country Club Road Shares Outstanding 25 M Compensation Risk 8
Price Hint 4 Target High Price 0.0000 Website https://acceleratediagnostics.com
52 Week Change -0.6273 Average Volume 62806 Forward Eps -1.71
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 89.70 %
Last Split Factor 1:10 Regular Market Day High 1.68 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 5.23 Day High 1.68
Shares Short 473079 Regular Market Open 1.58 Industry Key medical-devices
Earnings Growth 0.00 % Enterprise To Revenue 6.48 Revenue Growth 2.20 %
Shares Percent Shares Out 0.0200 Operating Cashflow -32043000 Currency USD
Time Zone Full Name America/New_York Market Cap 40 M Is_nasdaq_100 False
Zip 85714 Quote Type EQUITY Industry Medical Devices
Long Name Accelerate Diagnostics, Inc. Overall Risk 5 Regular Market Day Low 1.58
Held Percent Institutions 0.1745 Current Price 1.61 Address2 Suite 470 4th Floor
Enterprise To Ebitda -1.95 Financial Currency USD Current Ratio 1.28
Gross Margins 17.48 % Industry Disp Medical Devices Country United States
Float Shares 12 M Two Hundred Day Average 1.35 Governance Epoch Date 1 B
Enterprise Value 79 M Price To Sales Trailing12 Months 3.30 Forward PE -0.9415
Regular Market Volume 44521 Ebitda -40770000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East.

The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.

It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.

The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012.

Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.